Cite
Zinc and Its Antioxidant Properties: The Potential Use of Blood Zinc Levels as a Marker of Cancer Risk in BRCA1 Mutation Carriers.
MLA
Matuszczak, Milena, et al. “Zinc and Its Antioxidant Properties: The Potential Use of Blood Zinc Levels as a Marker of Cancer Risk in BRCA1 Mutation Carriers.” Antioxidants (Basel, Switzerland), vol. 13, no. 5, May 2024. EBSCOhost, https://doi.org/10.3390/antiox13050609.
APA
Matuszczak, M., Kiljańczyk, A., Marciniak, W., Derkacz, R., Stempa, K., Baszuk, P., Bryśkiewicz, M., Sun, P., Cheriyan, A., Cybulski, C., Dębniak, T., Gronwald, J., Huzarski, T., Lener, M. R., Jakubowska, A., Szwiec, M., Stawicka-Niełacna, M., Godlewski, D., Prusaczyk, A., … Lubiński, J. (2024). Zinc and Its Antioxidant Properties: The Potential Use of Blood Zinc Levels as a Marker of Cancer Risk in BRCA1 Mutation Carriers. Antioxidants (Basel, Switzerland), 13(5). https://doi.org/10.3390/antiox13050609
Chicago
Matuszczak, Milena, Adam Kiljańczyk, Wojciech Marciniak, Róża Derkacz, Klaudia Stempa, Piotr Baszuk, Marta Bryśkiewicz, et al. 2024. “Zinc and Its Antioxidant Properties: The Potential Use of Blood Zinc Levels as a Marker of Cancer Risk in BRCA1 Mutation Carriers.” Antioxidants (Basel, Switzerland) 13 (5). doi:10.3390/antiox13050609.